<DOC>
	<DOCNO>NCT00776438</DOCNO>
	<brief_summary>To characterize immune response induce influenza vaccination perform either via ID IM rout two clearly distinct population . Objectives : - To describe immune response per age group vaccine group vaccination . - To describe safety vaccine per age group per vaccine group vaccination .</brief_summary>
	<brief_title>Study Immune Response Adults Elderly Subjects Vaccinated With Inactivated Influenza Vaccines</brief_title>
	<detailed_description />
	<mesh_term>Infection</mesh_term>
	<mesh_term>Communicable Diseases</mesh_term>
	<mesh_term>Influenza , Human</mesh_term>
	<mesh_term>Orthomyxoviridae Infections</mesh_term>
	<mesh_term>Vaccines</mesh_term>
	<criteria>Inclusion Criteria : Aged 18 40 year ( adult ) 60 85 year ( elderly ) Provision sign informed consent Able attend schedule visit comply trial procedure For woman childbearing potential , avoid become pregnant ( use effective method contraception abstinence ) least 4 week prior vaccination , 4 week vaccination Entitlement national social security . Exclusion Criteria : For woman childbearing potential , known pregnancy positive urine pregnancy test Breastfeeding woman Participation another clinical trial investigate vaccine , drug , medical device medical procedure 4 week precede trial vaccination Planned participation another clinical trial present trial period Known suspect congenital acquire immunodeficiency , immunosuppressive therapy anticancer chemotherapy radiation therapy within precede 6 month , longterm systemic corticosteroid therapy Known systemic hypersensitivity vaccine component history lifethreatening reaction trial vaccine vaccine contain substance Chronic illness , stage could interfere trial conduct completion , opinion Investigator Current alcohol abuse drug addiction , may interfere subject 's ability comply trial procedure Receipt blood bloodderived product past 3 month , might interfere assessment immune response Receipt vaccine 4 week precede trial vaccination Planned receipt vaccine 4 week follow trial vaccination Known Human Immunodeficiency Virus , Hepatitis B Hepatitis C seropositivity Previous vaccination Influenza previous 6 month Thrombocytopenia , bleed disorder anticoagulant 3 week precede inclusion contraindicate IM vaccination Subject deprive freedom administrative court order , emergency setting , hospitalize without his/her consent Febrile illness ( oral temperature &gt; =37.5Â°C ) moderate severe acute illness/infection day vaccination , accord investigator judgment</criteria>
	<gender>All</gender>
	<minimum_age>18 Years</minimum_age>
	<maximum_age>85 Years</maximum_age>
	<verification_date>June 2015</verification_date>
	<keyword>Influenza</keyword>
	<keyword>Orthomyxoviruses</keyword>
	<keyword>Myxovirus Infection</keyword>
	<keyword>Inactivated Split-virion influenza vaccine</keyword>
	<keyword>Adults</keyword>
	<keyword>Elderly</keyword>
</DOC>